Organon & Co | Umlaufvermögen



Current Assets Veränderung Datum
Adcock Ingram Holdings ZAR 5.12B 234.71M 2024-12
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Celltrion KRW 5.46T 122.95B 2025-03
Cspc Pharmaceutical CNY 21.89B 4.58B 2024-12
Dianthus Therapeutics USD 280.9M 6.58M 2024-12
Divis Laboratories Ltd 100.81B 7.4B 2025-03
Gilead Sciences USD 14.72B 2.18B 2025-06
Glaxosmithkline GBP 17B 301M 2024-12
Kangmei Pharma CNY 6.89B 6.07M 2025-03
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Laboratorios Farma EUR 489.61M 51.17M 2024-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.41M 7.26M 2024-12
Merck USD 37.07B 1.56B 2025-06
Neuren Pharmaceuticals AUD 399.33M 171.29M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Organigram Holdings CAD 231.49M 30.73M 2024-12
Organon & Co USD 4.62B 247M 2025-06
Pharma Mar EUR 249.4M 13.39M 2025-06
Qiagen NV USD 1.82B 76.12M 2025-06
Sartorius EUR 2.17B 7.5M 2025-06
Sino Biopharmaceutical CNY 24.69B 536.66M 2024-12
Tilray USD 707.34M 18.54M 2024-11


Organon & Co Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.